Viactiv Growth Bolsters Mead Johnson 3Q Sales
This article was originally published in The Tan Sheet
Executive Summary
Viactiv calcium chews' sales growth continues to be a strong point for Bristol-Myers Squibb's Mead Johnson division. Sales of Viactiv leaped 40% over the prior-year period to $14 mil., continuing the brand's pace to double its sales from its first year on the market.